Tsuda Y, Mashimo T, Yoshiya I, Kaseda K, Harada Y, Yanagida T
Department of Anesthesiology, Osaka University Medical School, Japan.
Biophys J. 1996 Nov;71(5):2733-41. doi: 10.1016/S0006-3495(96)79466-3.
Using a recently developed in vitro motility assay, we have demonstrated that local anesthetics directly inhibit myosin-based movement of single actin filaments in a reversible dose-dependent manner. This is the first reported account of the actions of local anesthetics on purified proteins at the molecular level. In this study, two tertiary amine local anesthetics, lidocaine and tetracaine, were used. The inhibitory action of the local anesthetics on actomyosin sliding movement was pH dependent; the anesthetics were more potent at higher pH values, and this reaction was accompanied by an increased proportion of the uncharged form of the anesthetics. QX-314, a permanently charged derivative of lidocaine, had no effect on actomyosin sliding movement. These results indicate that the uncharged form of local anesthetics is predominantly responsible for the inhibition of actomyosin sliding movement. The local anesthetics inhibited sliding movement but hardly interfered with the binding of actin filaments to myosin on the surface or with actomyosin ATPase activity at low ionic strength. To characterize the actomyosin interaction in the presence of anesthetics, we measured the binding and breaking force of the actomyosin complex. The binding of actin filaments to myosin on the surface was not affected by lidocaine at low ionic strength. The breaking force, measured using optical tweezers, was approximately 1.5 pN per micron of an actin filament, which was much smaller than in rigor and isometric force. The binding and breaking force greatly decreased with increasing ionic strength, indicating that the remaining interaction is ionic in nature. The result suggests that the binding and ATPase of actomyosin are governed predominantly by ionic interaction, which is hardly affected by anesthetics; whereas the force generation requires hydrophobic interaction, which plays a major part of the strong binding and is blocked by anesthetics, in addition to the ionic interaction.
使用最近开发的体外运动分析方法,我们已经证明局部麻醉药以可逆的剂量依赖性方式直接抑制单根肌动蛋白丝基于肌球蛋白的运动。这是首次在分子水平上报道局部麻醉药对纯化蛋白质作用的研究。在本研究中,使用了两种叔胺类局部麻醉药,利多卡因和丁卡因。局部麻醉药对肌动球蛋白滑动运动的抑制作用依赖于pH值;在较高pH值下,麻醉药的效力更强,并且这种反应伴随着麻醉药非带电形式比例的增加。QX-314是利多卡因的一种永久带电衍生物,对肌动球蛋白滑动运动没有影响。这些结果表明局部麻醉药的非带电形式主要负责抑制肌动球蛋白滑动运动。局部麻醉药抑制滑动运动,但在低离子强度下几乎不干扰肌动蛋白丝与肌球蛋白在表面的结合或肌动球蛋白ATP酶活性。为了表征在麻醉药存在下肌动球蛋白的相互作用,我们测量了肌动球蛋白复合物的结合力和断裂力。在低离子强度下,肌动蛋白丝与肌球蛋白在表面的结合不受利多卡因影响。使用光镊测量的断裂力约为每微米肌动蛋白丝1.5皮牛,这比强直收缩力和等长收缩力小得多。随着离子强度的增加,结合力和断裂力大大降低,表明剩余的相互作用本质上是离子性的。结果表明,肌动球蛋白的结合和ATP酶活性主要由离子相互作用控制,而离子相互作用几乎不受麻醉药影响;而力的产生需要疏水相互作用,疏水相互作用在强结合中起主要作用,除离子相互作用外,还被麻醉药阻断。